跳至主要内容
临床试验/NCT06128915
NCT06128915招募中4 期

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

State University of New York at Buffalo1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年1月8日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
60
试验地点
1
主要终点
Pneumococcal Opsonophagocytic Killing Activity (OPH) by neutrophils from young versus old donors at 1 week and 1 month after vaccination

研究概览

简要总结

This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.

详细描述

This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar in young and elderly adults. This study involves direct vaccination of human volunteers. The endpoints will be determining how vaccination affects neutrophil responses and linking those neutrophil responses to antibody responses following vaccination. The main results will be:

  1. Elucidating how neutrophils kill bacteria before and after vaccination
  2. Elucidate the phenotype of neutrophils before and after vaccination
  3. Elucidate how neutrophils interact with B and T cell in vitro before and after vaccination
  4. Measure antibody levels and function before and after vaccination
  5. Correlate neutrophil responses to antibody levels and function

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

盲法说明

Enrolled participants will be assigned a unique study identification number followed by a visit number (example 1.1 for donor #1-first visit). The code list, linking patient identities (such as names/phone numbers) and samples, will be kept in a separate file locked in a drawer the PI's office. The code list and code-identified data will be stored in separate locations and only authorized individuals will have access to the list. Experiments and data analysis will be performed only on coded samples and researchers will only have access to the visit number as the experiments to be performed on the collected samples pre and post vaccination differ.

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Both sexes
  • Have not been vaccinated with any licensed or experimental pneumococcal vaccine
  • Ages 21-40; and ≥
  • Individuals >60 years old will also be recruited in case we find no unvaccinated people ≥65 years old
  • Free of acute infections within the last 2 weeks
  • Did not take any anti-inflammatory medicine in the last week
  • Did not ingest alcohol in the last 24 hours
  • Ability and willingness to provide consent

排除标准

  • Previous vaccination with any licensed or experimental pneumococcal vaccine
  • Known hypersensitivity to vaccination and vaccine components
  • Immune deficiency
  • Use of immune-modulating or suppressive drugs
  • Malignancies within the last 2 years
  • Known hematological, rheumatic and inflammatory diseases
  • Known chronic infections
  • Poorly controlled chronic cardiovascular and metabolic conditions
  • Pregnancy

研究组 & 干预措施

Vaccination with Prevnar.

Experimental

Intramuscular vaccination with Prevnar 20

干预措施: vaccine (Other)

结局指标

主要结局

Pneumococcal Opsonophagocytic Killing Activity (OPH) by neutrophils from young versus old donors at 1 week and 1 month after vaccination

时间窗: 1 month

OPH will be determined by measuring the percentage of S. pneumoniae bacteria killed in vitro by neutrophils from donors

次要结局

  • Surface phenotype of neutrophils from young versus old donors at 1 week and 1 month after vaccination(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elsa Bou Ghanem

Principal Investigator

State University of New York at Buffalo

研究点 (1)

Loading locations...

相似试验